Valneva SE ADR (VALN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $538.42M
Last updated: Nov 17, 2026 at 10:33 AM ET
Valneva SE ADR (VALN) Financials: Revenue, Profit and Cash Flow
Valneva SE ADR reported revenue of EUR 174.66M for the fiscal year ended Dec 31, 2025, up 3.0% from the year before. That year, net income was EUR -115.19M with a net margin of -66.0%, operating cash flow was EUR -52.89M and free cash flow was EUR -57.38M. The quarter ended Jun 30, 2026 had revenue of EUR 35.52M and net income of EUR -31.72M.
Revenue and Margins
The operating margin was -46.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from EUR 94.06M, a compound annual rate of 7.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 174.66M | +3.0% | 38.7% | -46.7% | -66.0% |
| Dec 2024 | 169.58M | +10.3% | 41.9% | 7.9% | -7.2% |
| Dec 2023 | 153.71M | -57.5% | 34.4% | -53.4% | -66.0% |
| Dec 2022 | 361.30M | +3.8% | 10.2% | -31.4% | -39.7% |
| Dec 2021 | 348.08M | +215.5% | 46.0% | -17.6% | -21.1% |
| Dec 2020 | 110.32M | -12.6% | 50.8% | -50.0% | -58.4% |
| Dec 2019 | 126.20M | +11.6% | 60.4% | -0.6% | -1.4% |
| Dec 2018 | 113.03M | +7.4% | 61.6% | 5.5% | 2.9% |
| Dec 2017 | 105.29M | +11.9% | 56.3% | -3.8% | -10.9% |
| Dec 2016 | 94.06M | N/A | 54.2% | -45.3% | -52.3% |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 174.66M | 169.58M | 153.71M | 361.30M | 348.08M | 110.32M | 126.20M | 113.03M | 105.29M | 94.06M |
| Cost of revenue | 107.14M | 98.54M | 100.88M | 324.44M | 187.92M | 54.30M | 49.97M | 43.43M | 45.98M | 43.08M |
| Gross profit | 67.52M | 71.04M | 52.84M | 36.86M | 160.16M | 56.02M | 76.23M | 69.60M | 59.31M | 50.99M |
| Research and development | 85.30M | 74.14M | 59.89M | 104.92M | 173.28M | 84.45M | 37.88M | 12.19M | 23.36M | 24.59M |
| Operating income | -81.63M | 13.33M | -82.09M | -113.44M | -61.39M | -55.11M | -811.00K | 6.26M | -3.95M | -42.57M |
| Net income | -115.19M | -12.25M | -101.43M | -143.28M | -73.42M | -64.39M | -1.74M | 3.26M | -11.48M | -49.18M |
| EBITDA | -50.47M | 32.08M | -57.72M | -104.72M | -38.73M | -44.76M | 10.29M | 12.85M | 3.64M | -31.47M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 35.52M | 30.90M | 47.69M | 29.41M | 48.33M | 49.23M | 52.94M | 45.82M | 38.06M | 32.75M | 41.90M | 38.07M |
| Gross profit | 1.63M | 4.72M | 11.62M | 5.50M | 24.21M | 26.19M | 25.71M | 20.15M | 14.59M | 10.59M | 15.83M | 17.10M |
| Operating income | -27.64M | -23.70M | -27.68M | -37.12M | -10.87M | -5.96M | -20.88M | -12.45M | -21.55M | 68.21M | -24.91M | -22.21M |
| Net income | -31.72M | -32.07M | -50.02M | -44.35M | -11.59M | -9.23M | -36.99M | -9.24M | -24.93M | 58.91M | -32.16M | -34.23M |
Balance Sheet
As of Dec 2025, total debt of EUR 181.91M exceeded cash and equivalents by 72.25M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 398.84M | 500.03M | 460.06M | 621.34M | 817.35M | 449.16M | 264.72M | 229.91M | 189.34M | 206.88M |
| Current assets | 222.54M | 299.01M | 262.82M | 424.66M | 585.83M | 308.43M | 129.16M | 125.97M | 83.45M | 91.20M |
| Cash and equivalents | 109.65M | 168.27M | 126.08M | 289.43M | 346.64M | 204.39M | 64.44M | 77.08M | 33.55M | 35.27M |
| Total liabilities | 292.67M | 318.78M | 331.81M | 401.55M | 646.77M | 371.74M | 129.57M | 86.72M | 96.67M | 106.83M |
| Short-term debt | 20.64M | 23.36M | 46.96M | 36.99M | 10.24M | 9.68M | 4.31M | 17.53M | 17.40M | 20.96M |
| Long-term debt | 161.26M | 166.52M | 132.77M | 87.23M | 50.73M | 46.38M | 24.32M | 14.27M | 27.43M | N/A |
| Shareholder equity | 106.17M | 181.25M | 128.25M | 219.80M | 170.58M | 77.42M | 135.15M | 143.19M | 92.67M | 100.05M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 388.12M | 372.40M | 398.84M | 448.23M | 472.63M | 482.24M | 500.03M | 516.61M | 466.57M | 502.83M | 469.39M | 520.54M |
| Total liabilities | 307.03M | 295.31M | 292.67M | 297.75M | 286.19M | 306.99M | 318.78M | 299.14M | 300.29M | 313.60M | 331.81M | 363.02M |
| Cash and equivalents | 121.48M | 105.37M | 109.65M | 143.46M | 161.31M | 152.99M | 168.27M | 156.34M | 131.41M | 176.64M | 126.08M | 171.25M |
| Shareholder equity | 81.09M | 76.78M | 106.17M | 150.48M | 186.43M | 175.25M | 181.25M | 217.47M | 166.28M | 189.23M | 137.58M | 157.52M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -52.89M | -67.22M | -202.74M | -245.34M | 76.90M | 137.74M | 5.53M | 16.31M | 12.83M | 6.50M |
| Capital expenditures | 4.48M | 16.44M | 14.31M | 29.32M | 93.17M | 19.47M | 10.88M | 3.17M | 4.04M | 3.68M |
| Free cash flow | -57.38M | -83.66M | -217.06M | -274.67M | -16.27M | 118.27M | -5.36M | 13.13M | 8.79M | 2.82M |
| Investing cash flow | -1.71M | 76.92M | -20.59M | -29.05M | -93.12M | -19.34M | -10.69M | -2.92M | -4.06M | 14.89M |
| Financing cash flow | -621.00K | 30.68M | 63.08M | 215.12M | 154.50M | 21.74M | -7.70M | 30.95M | -10.44M | -26.79M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -18.46M | -313.00K | -46.94M | -17.44M | -2.79M | -8.15M | 5.45M | -10.48M | -37.83M | -28.43M | -65.91M | -71.40M |
| Capital expenditures | 349.47K | 252.00K | 1.25M | 668.00K | 1.25M | 1.47M | 4.24M | 15.90M | 394.00K | 4.53M | 5.92M | 1.22M |
| Free cash flow | -18.81M | -565.00K | -48.19M | -18.11M | -4.05M | -9.62M | 1.21M | -26.39M | -38.22M | -32.96M | -71.83M | -72.62M |
Frequently Asked Questions About VALN
What is Valneva SE ADR's annual revenue?
Valneva SE ADR reported revenue of EUR 174.66M for the fiscal year ended Dec 31, 2025.
How fast is Valneva SE ADR's revenue growing?
Revenue was up 3.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -21.5%.
Is Valneva SE ADR profitable?
No. Valneva SE ADR reported net income of EUR -115.19M for the fiscal year ended Dec 31, 2025, with a net margin of -66.0%.
How much free cash flow does VALN generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of EUR -52.89M minus capital expenditures of EUR 4.48M produced free cash flow of EUR -57.38M.
How much debt does Valneva SE ADR have?
The balance sheet dated Dec 31, 2025 reported long-term debt of EUR 161.26M, short-term debt of EUR 20.64M and cash and equivalents of EUR 109.65M.
VALN pages: Overview, Financials, Competitors